Allergies

  1. Home
  2. Health
  3. Allergies
photo of Daniel More, MD

Allergies Blog

By Daniel More, MD, About.com Guide to Allergies

Alvesco - An Inhaled Steroid Without the Side Effects?

Saturday August 2, 2008
Many people are hesitant to take inhaled steroids for their asthma based on concern for inhaled steroid side effects. So, if a new inhaled steroid became available, which didn't cause the major side effects of other inhaled steroids, more asthmatics would be more likely to take it.

Alvesco (ciclesonide), is the inhaled version of Omnaris, a new medication that has minimal steroid effects until it is turned into its active form within the respiratory tract. As a result, it acts only as a steroid where it should (the lungs), and doesn't where it shouldn't. And, for people who are prone to developing thrush from inhaled steroids, Alvesco could be just what the doctor ordered.

Comments

August 23, 2008 at 12:00 am
(1) Kathy says:

What about people who are allergic to inhaled steroids.Could this one work and is it available in Canada.???

September 8, 2008 at 3:22 pm
(2) salmonfishpie says:

I am on my first Alvesco inhaler and I have a question as to how I could tell when the inhaler is empty.
I use Symbicort before and at least there is an indicator on the bottle.

October 9, 2008 at 5:27 pm
(3) salmonfishpie says:

Will Alvesco or other inhaled corticosteroid cause fatty liver? I heard that corticosteroid affect the deposition of fat in the body, is that true?

November 7, 2008 at 8:59 pm
(4) Nancy says:

Thanks for the info- on non-allergic rhinitis. Please advise wher my 21 years old son cah get help? (NY area). He is suffering for over 2 years with morning snizzing, running nose, and allergies have been ruled out.
Thank you very much.
Nancy

Leave a Comment

Line and paragraph breaks are automatic. Some HTML allowed: <a href="" title="">, <b>, <i>, <strike>

Discuss

Community Forum

Explore Allergies

About.com Special Features

Allergies

  1. Home
  2. Health
  3. Allergies

©2009 About.com, a part of The New York Times Company.

All rights reserved.